Table 3.
Patient related risk factors for bleeding in patients with and without DB
| EMR without DB N = 37 | EMR with DB N = 7 | P value | |
|---|---|---|---|
| Age in years, median (IQR) | 68.0 (57.0–72.5) | 73.0 (54.0–80.0) | NS |
| Cardiovascular comorbidity, n (%) | 19 (51.4) | 3 (42.9) | NS |
| Anticoagulant use, n (%) | NS | ||
| No | 25 (67.6) | 4 (57.1) | |
| Antiplatelet | 6 (16.2) | 2 (28.6) | |
| Vit K antagonists | 4 (10.8) | 1 (14.3) | |
| Combination therapya | 1 (2.7) | – | |
| DOAC/NOAC | 1 (2.7) | – | |
| Lesion location, n (%) | NS | ||
| Esophagus | 15 (40.5) | 1 (14.3) | |
| Duodenum | 7 (18.9) | 4 (57.1) | |
| Colorectum | 15 (40.5) | 2 (28.6) | |
| Specified location colorectum, n (%) | NS | ||
| Right sided | 7 (46.7) | – | |
| Left sided | 8 (53.3) | 2 (100) | |
| Lesion size in cm2, median (IQR) | 0.04 | ||
| Esophagus | 3.5 (2–6) | 4 (4–4) | |
| Duodenum | 8.5 (2–10) | 8.3 (4.5–10.9) | |
| Colorectum | 4 (2–12.5) | 25.5 (NAb) | |
| Piecemeal resection, n (%) | 32 (86.5) | 7 (100) | NS |
| Average number of pieces | 3.3 | 6.6 | NS |
EMR endoscopic mucosal resection, DB delayed bleeding, IQR interquartile range, NS not significant, Vit K antagonists vitamin K antagonists, DOAC/NOAC direct oral anticoagulants/new oral anticoagulants
aCombination therapy defined as concurrent use of aspirin and acenocoumarin
bNA not applicable